Document is current

Any future updates will be listed below

IL-17A-Antikörper für Psoriasis-Arthritis zugelassen

Crossref DOI link: https://doi.org/10.1007/s15012-018-2761-2

Published Online: 2018-05-12

Published Print: 2018-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark